Neuroimmune signaling in neuropsychiatric disease.
- Published in:
- 2019
- By:
- Publication type:
- Editorial
Works matching IS 00333158 AND DT 2019 AND VI 236 AND IP 10
Results: 16
1
2
Stress, sex hormones, inflammation, and major depressive disorder: Extending Social Signal Transduction Theory of Depression to account for sex differences in mood disorders.
- Published in:
- Psychopharmacology, 2019, v. 236, n. 10, p. 3063, doi. 10.1007/s00213-019-05326-9
- By:
- Publication type:
- Article
3
Beyond the brain: A multi-system inflammatory subtype of autism spectrum disorder.
- Published in:
- Psychopharmacology, 2019, v. 236, n. 10, p. 3045, doi. 10.1007/s00213-019-05280-6
- By:
- Publication type:
- Article
4
GABA<sub>A</sub>R α2-activated neuroimmune signal controls binge drinking and impulsivity through regulation of the CCL2/CX3CL1 balance.
- Published in:
- Psychopharmacology, 2019, v. 236, n. 10, p. 3023, doi. 10.1007/s00213-019-05220-4
- By:
- Publication type:
- Article
5
Targeting neuroinflammation with minocycline in heavy drinkers.
- Published in:
- Psychopharmacology, 2019, v. 236, n. 10, p. 3013, doi. 10.1007/s00213-019-05205-3
- By:
- Publication type:
- Article
6
Inflammation in cancer and depression: a starring role for the kynurenine pathway.
- Published in:
- Psychopharmacology, 2019, v. 236, n. 10, p. 2997, doi. 10.1007/s00213-019-05200-8
- By:
- Publication type:
- Article
7
An IL-6 receptor antagonist attenuates postpartum anhedonia, but has no effect on anhedonia precipitated by subchronic stress in female rats.
- Published in:
- Psychopharmacology, 2019, v. 236, n. 10, p. 2983, doi. 10.1007/s00213-019-05194-3
- By:
- Publication type:
- Article
8
Lipocalin-2 is dispensable in inflammation-induced sickness and depression-like behavior.
- Published in:
- Psychopharmacology, 2019, v. 236, n. 10, p. 2975, doi. 10.1007/s00213-019-05190-7
- By:
- Publication type:
- Article
9
Ethanol induces interferon expression in neurons via TRAIL: role of astrocyte-to-neuron signaling.
- Published in:
- Psychopharmacology, 2019, v. 236, n. 10, p. 2881, doi. 10.1007/s00213-018-5153-8
- By:
- Publication type:
- Article
10
ADHD pathogenesis in the immune, endocrine and nervous systems of juvenile and maturating SHR and WKY rats.
- Published in:
- Psychopharmacology, 2019, v. 236, n. 10, p. 2937, doi. 10.1007/s00213-019-5180-0
- By:
- Publication type:
- Article
11
A biocultural approach to psychiatric illnesses.
- Published in:
- Psychopharmacology, 2019, v. 236, n. 10, p. 2923, doi. 10.1007/s00213-019-5178-7
- By:
- Publication type:
- Article
12
Psychopharmacology: neuroimmune signaling in psychiatric disease-developing vaccines against abused drugs using toll-like receptor agonists.
- Published in:
- Psychopharmacology, 2019, v. 236, n. 10, p. 2899, doi. 10.1007/s00213-019-5176-9
- By:
- Publication type:
- Article
13
Targeting the immune system in the treatment of bipolar disorder.
- Published in:
- Psychopharmacology, 2019, v. 236, n. 10, p. 2909, doi. 10.1007/s00213-019-5175-x
- By:
- Publication type:
- Article
14
Interleukin-4 signalling pathway underlies the anxiolytic effect induced by 3-deoxyadenosine.
- Published in:
- Psychopharmacology, 2019, v. 236, n. 10, p. 2959, doi. 10.1007/s00213-019-5186-7
- By:
- Publication type:
- Article
15
The selenium-containing compound 3-((4-chlorophenyl)selanyl)-1-methyl-1H-indole reverses depressive-like behavior induced by acute restraint stress in mice: modulation of oxido-nitrosative stress and inflammatory pathway.
- Published in:
- Psychopharmacology, 2019, v. 236, n. 10, p. 2867, doi. 10.1007/s00213-018-5151-x
- By:
- Publication type:
- Article
16
Minocycline does not affect experimental pain or addiction-related outcomes in opioid maintained patients.
- Published in:
- Psychopharmacology, 2019, v. 236, n. 10, p. 2857, doi. 10.1007/s00213-018-5146-7
- By:
- Publication type:
- Article